BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7219079)

  • 21. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets.
    Lin CH; Kuo SC; Huang LJ; Huang TF; Teng CM
    Thromb Res; 1992 Apr; 66(1):61-73. PubMed ID: 1412184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of aggregation and thromboxane B2 synthesis in avian thrombocytes: comparison between atherosclerosis-susceptible and resistant breeds.
    Subbiah MT; Yunker R; Gallon L
    Thromb Haemost; 1980 Jul; 43(3):189-91. PubMed ID: 7455983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased production of platelet thromboxane B2 in non-insulin-dependent diabetes. Relationship to vascular complications.
    D'Angelo A; Micossi P; Mannucci PM; Garimberti B; Franchi F; Pozza G
    Eur J Clin Invest; 1984 Apr; 14(2):83-6. PubMed ID: 6428908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of thrombocyte aggregation and thromboxane B2 synthesis by diethylstilbestrol.
    Subbiah MT; Gallon L; Yunker R
    Pharmacology; 1980; 21(6):396-9. PubMed ID: 7220591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formation of thromboxane B2 by platelets and concentrations of thromboxane B2 and 6-keto-prostaglandin F1 alpha in plasma after acute ethanol ingestion.
    Kangasaho M; Hillbom M; Kaste M; Wuorela H; Vapaatalo H
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():223-8. PubMed ID: 6303086
    [No Abstract]   [Full Text] [Related]  

  • 26. Differential activation of platelet phospholipases by thrombin and ionophore A23187.
    Rittenhouse-Simmons S
    J Biol Chem; 1981 May; 256(9):4153-5. PubMed ID: 6783655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in thromboxane formation by platelets during and after a continuous endotoxin infusion into rabbits.
    Ditter H; Matthias FR
    Vasa; 1984; 13(4):327-32. PubMed ID: 6516562
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of dietary fat type on prostaglandin E production in vivo.
    von Houwelingen AC; Hennissen AH; Seyberth HW; Hornstra G
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():871-5. PubMed ID: 2960201
    [No Abstract]   [Full Text] [Related]  

  • 29. Phospholipase A2 activity in platelets of patients with uremia.
    Vecino AM; Teruel JL; Navarro JL; Cesar JM
    Platelets; 2002 Nov; 13(7):415-8. PubMed ID: 12487789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet thromboxane production during endotoxin shock.
    Prancan A; Simon D; Pope L
    Agents Actions; 1981 Dec; 11(6-7):648-50. PubMed ID: 7340458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions.
    Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M
    Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of chronic administration of ethanol on platelets from rabbits with diet-induced hypercholesterolemia. Unchanged characteristics and responses to ADP but reduction of enhanced thrombin-induced, TxA2-independent platelet responses.
    Latta EK; Packham MA; DaCosta SM; Rand ML
    Arterioscler Thromb; 1994 Aug; 14(8):1372-7. PubMed ID: 8049200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that extracellular calcium ions inhibit thromboxane B2 biosynthesis by human platelets.
    Best LC; Jones PB; Russell RG
    Biochem Biophys Res Commun; 1979 Oct; 90(4):1179-85. PubMed ID: 117802
    [No Abstract]   [Full Text] [Related]  

  • 34. Modifications of platelet phospholipid fatty acid composition in streptozocin-induced diabetic rats.
    Dang AQ; Faas FH; Jethmalani SM; Carter WJ
    Prostaglandins Leukot Essent Fatty Acids; 1992 Sep; 47(1):17-22. PubMed ID: 1438463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-density lipoproteins supply phospholipid-bound arachidonic acid for platelet eicosanoid production.
    Dobner P; Engelmann B
    Am J Physiol; 1998 Nov; 275(5):E777-84. PubMed ID: 9814996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin reduces platelet hypersensitivity in hypercholesterolemic rabbits.
    Tremoli E; Ghiselli G; Maderna P; Colli S; Sirtori CR
    Atherosclerosis; 1982 Jan; 41(1):53-60. PubMed ID: 7073794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The inhibition of arachidonic acid metabolism in human platelets by RHC 80267, a diacylglycerol lipase inhibitor.
    Oglesby TD; Gorman RR
    Biochim Biophys Acta; 1984 Apr; 793(2):269-77. PubMed ID: 6424715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A dominant role of thromboxane formation in secondary aggregation of platelets.
    Meyers KM; Seachord CL; Holmsen H; Smith JB; Prieur DJ
    Nature; 1979 Nov; 282(5736):331-3. PubMed ID: 503210
    [No Abstract]   [Full Text] [Related]  

  • 39. Phospholipid metabolism in human platelets preserved at 22 degrees C: differential effects of storage on phospholipase A2- and C-mediated reactions.
    Imai A; Takahashi M; Nozawa Y
    Cryobiology; 1984 Jun; 21(3):255-9. PubMed ID: 6734238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arachidonic acid of platelet phospholipids is decreased after extracorporeal removal of plasma low density lipoproteins in patients with familial hypercholesterolemia.
    Bräutigam R; Bräutigam C; Lorenz R; Richter WO; Engelmann B
    Atherosclerosis; 1997 May; 131(1):97-106. PubMed ID: 9180250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.